StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Adocia S.A.
Paris Stock Exchange:ADOC.PA
Sector
Location
Market Cap
USD 114.65 M
Share Price
USD 6.24
Avg Daily Volume
179,950
Change (1 day)
6.85%
Change (1 year)
-5.99%
Change (YTD)
0.21%
Adocia S.A. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2023: USD 6.05 M
Adocia S.A. Selling, General, and Administrative Expenses (SG&A) is USD 6.05 M for the year ending December 31, 2023. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
-
Adocia S.A. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2022 was USD 0.00.
-
Adocia S.A. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2021 was USD 0.00.
-
Adocia S.A. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2020 was USD 0.00, a -100.00% change year over year.
-
Adocia S.A. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2019 was USD 14.75 M, a -49.70% change year over year.
Competitors
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Novo Nordisk A/S
USD 70.34
NOVO-B.CO
+0.69
0.98%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
Novartis AG
USD 117.50
NOVN.SW
+0.23
0.19%
AstraZeneca PLC
USD 147.28
AZN.L
+2.35
1.62%
Abbott Laboratories
USD 125.64
ABT
-0.19
-0.15%
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
Amgen Inc.
USD 308.55
AMGN
-0.67
-0.22%
Pfizer Inc.
USD 25.35
PFE
-0.01
-0.04%
Gilead Sciences, Inc.
USD 113.20
GILD
-0.36
-0.32%
Vertex Pharmaceuticals Incorporated
USD 472.27
VRTX
-4.68
-0.98%
Sanofi
USD 100.09
SAN.PA
+0.48
0.48%
Bristol-Myers Squibb Company
USD 48.94
BMY
-0.04
-0.08%
CSL Limited
USD 177.62
CSL.AX
+2.36
1.34%
Chugai Pharmaceutical Co., Ltd.
USD 49.80
4519.T
+0.60
1.22%
GSK plc
USD 18.78
GSK.L
+0.16
0.83%
Regeneron Pharmaceuticals, Inc.
USD 564.64
REGN
-7.75
-1.35%
MERCK Kommanditgesellschaft auf Aktien
USD 133.12
MRK.DE
+0.98
0.74%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.04
600276.SS
+0.06
0.73%
Takeda Pharmaceutical Company Limited
USD 29.42
4502.T
-0.15
-0.50%
Key Data
| Date | Selling, General, and Administrative Expenses (SG&A) | Research and Development (R&D) Expenses | Revenue | Revenue |
|---|
Competitors
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Novo Nordisk A/S
USD 70.34
NOVO-B.CO
+0.69
0.98%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
Novartis AG
USD 117.50
NOVN.SW
+0.23
0.19%
AstraZeneca PLC
USD 147.28
AZN.L
+2.35
1.62%
Abbott Laboratories
USD 125.64
ABT
-0.19
-0.15%
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
Amgen Inc.
USD 308.55
AMGN
-0.67
-0.22%
Pfizer Inc.
USD 25.35
PFE
-0.01
-0.04%
Gilead Sciences, Inc.
USD 113.20
GILD
-0.36
-0.32%
Vertex Pharmaceuticals Incorporated
USD 472.27
VRTX
-4.68
-0.98%
Sanofi
USD 100.09
SAN.PA
+0.48
0.48%
Bristol-Myers Squibb Company
USD 48.94
BMY
-0.04
-0.08%
CSL Limited
USD 177.62
CSL.AX
+2.36
1.34%
Chugai Pharmaceutical Co., Ltd.
USD 49.80
4519.T
+0.60
1.22%
GSK plc
USD 18.78
GSK.L
+0.16
0.83%
Regeneron Pharmaceuticals, Inc.
USD 564.64
REGN
-7.75
-1.35%
MERCK Kommanditgesellschaft auf Aktien
USD 133.12
MRK.DE
+0.98
0.74%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.04
600276.SS
+0.06
0.73%
Takeda Pharmaceutical Company Limited
USD 29.42
4502.T
-0.15
-0.50%